| Genetics of rheumatoid arthritis contributes to biology and drug discovery Y Okada, D Wu, G Trynka, T Raj, C Terao, K Ikari, Y Kochi, K Ohmura, ... Nature 506 (7488), 376-381, 2014 | 2430 | 2014 |
| Which spinal lesions are associated with new bone formation in patients with ankylosing spondylitis treated with anti-TNF agents? A long-term observational study using MRI and … X Baraliakos, F Heldmann, J Callhoff, J Listing, T Appelboom, J Brandt, ... Annals of the rheumatic diseases 73 (10), 1819-1825, 2014 | 213 | 2014 |
| Association of fine specificity and repertoire expansion of anticitrullinated peptide antibodies with rheumatoid arthritis associated interstitial lung disease JT Giles, SK Danoff, J Sokolove, CA Wagner, R Winchester, DA Pappas, ... Annals of the rheumatic diseases 73 (8), 1487-1494, 2014 | 191 | 2014 |
| TYK2 Protein-Coding Variants Protect against Rheumatoid Arthritis and Autoimmunity, with No Evidence of Major Pleiotropic Effects on Non-Autoimmune Complex … D Diogo, L Bastarache, KP Liao, RR Graham, RS Fulton, JD Greenberg, ... PloS one 10 (4), e0122271, 2015 | 136 | 2015 |
| High-density genotyping of immune loci in Koreans and Europeans identifies eight new rheumatoid arthritis risk loci K Kim, SY Bang, HS Lee, SK Cho, CB Choi, YK Sung, TH Kim, JB Jun, ... Annals of the rheumatic diseases 74 (3), e13-e13, 2015 | 133 | 2015 |
| Machine learning to predict anti–tumor necrosis factor drug responses of rheumatoid arthritis patients by integrating clinical and genetic markers Y Guan, H Zhang, D Quang, Z Wang, SCJ Parker, DA Pappas, JM Kremer, ... Arthritis & Rheumatology 71 (12), 1987-1996, 2019 | 104 | 2019 |
| Postapproval comparative safety study of tofacitinib and biological Disease‐Modifying Antirheumatic drugs: 5‐Year results from a United States–based rheumatoid arthritis Registry JM Kremer, CO Bingham III, LC Cappelli, JD Greenberg, AM Madsen, ... ACR Open Rheumatology 3 (3), 173-184, 2021 | 100 | 2021 |
| Crowdsourced assessment of common genetic contribution to predicting anti-TNF treatment response in rheumatoid arthritis SK Sieberts, F Zhu, J García-García, E Stahl, A Pratap, G Pandey, ... Nature communications 7 (1), 12460, 2016 | 92 | 2016 |
| Myocardial citrullination in rheumatoid arthritis: a correlative histopathologic study JT Giles, J Fert-Bober, JK Park, CO Bingham, F Andrade, K Fox-Talbot, ... Arthritis research & therapy 14, 1-8, 2012 | 89 | 2012 |
| Herpes zoster reactivation in patients with rheumatoid arthritis: analysis of disease characteristics and disease‐modifying antirheumatic drugs DA Pappas, MM Hooper, JM Kremer, G Reed, Y Shan, D Wenkert, ... Arthritis Care & Research 67 (12), 1671-1678, 2015 | 87 | 2015 |
| A weighted genetic risk score using all known susceptibility variants to estimate rheumatoid arthritis risk A Yarwood, B Han, S Raychaudhuri, J Bowes, M Lunt, DA Pappas, ... Annals of the rheumatic diseases 74 (1), 170-176, 2015 | 70 | 2015 |
| Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritis AJ Ocon, G Reed, DA Pappas, JR Curtis, JM Kremer Annals of the rheumatic diseases 80 (12), 1522-1529, 2021 | 57 | 2021 |
| Brief Report: Identification of BACH2 and RAD51B as Rheumatoid Arthritis Susceptibility Loci in a Meta‐Analysis of Genome‐Wide Data K McAllister, A Yarwood, J Bowes, G Orozco, S Viatte, D Diogo, ... Arthritis & Rheumatism 65 (12), 3058-3062, 2013 | 54 | 2013 |
| Respiratory symptoms and disease characteristics as predictors of pulmonary function abnormalities in patients with rheumatoid arthritis: an observational cohort study DA Pappas, JT Giles, G Connors, N Lechtzin, JM Bathon, SK Danoff Arthritis research & therapy 12, 1-11, 2010 | 54 | 2010 |
| Integration of Sequence Data from a Consanguineous Family with Genetic Data from an Outbred Population Identifies PLB1 as a Candidate Rheumatoid Arthritis … Y Okada, D Diogo, JD Greenberg, F Mouassess, WAL Achkar, RS Fulton, ... PLoS One 9 (2), e87645, 2014 | 44 | 2014 |
| Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis S Lillegraven, JD Greenberg, GW Reed, K Saunders, JR Curtis, L Harrold, ... PLoS One 14 (1), e0210459, 2019 | 43 | 2019 |
| Comparative effectiveness of first-line tumour necrosis factor inhibitor versus non-tumour necrosis factor inhibitor biologics and targeted synthetic agents in patients with … DA Pappas, G St John, CJ Etzel, S Fiore, T Blachley, T Kimura, R Punekar, ... Annals of the Rheumatic Diseases 80 (1), 96-102, 2021 | 42 | 2021 |
| Golimumab. DA Pappas, JM Bathon, D Hanicq, U Yasothan, P Kirkpatrick Nature reviews Drug Discovery 8 (9), 2009 | 40 | 2009 |
| Prevalence of cardiovascular disease and major risk factors in patients with rheumatoid arthritis: a multinational cross-sectional study DA Pappas, F Nyberg, JM Kremer, K Lampl, GW Reed, L Horne, M Ho, ... Clinical rheumatology 37, 2331-2340, 2018 | 39 | 2018 |
| Design characteristics of the CORRONA CERTAIN study: a comparative effectiveness study of biologic agents for rheumatoid arthritis patients DA Pappas, JM Kremer, G Reed, JD Greenberg, JR Curtis BMC Musculoskeletal Disorders 15, 1-10, 2014 | 38 | 2014 |
